Risk Assessment Tools in Pulmonary Arterial Hypertension. Prognosis for Prospective Trials?
Author:
Affiliation:
1. Pulmonary CenterBoston University School of MedicineBoston, Massachusettsand
2. The Cardiovascular InstituteAllegheny General HospitalPittsburgh, Pennsylvania
Publisher
American Thoracic Society
Subject
Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Link
http://www.atsjournals.org/doi/pdf/10.1164/rccm.201801-0042ED
Reference12 articles.
1. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
2. Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study
3. Evaluation of the Predictive Value of a Clinical Worsening Definition Using 2-Year Outcomes in Patients With Pulmonary Arterial Hypertension
4. The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?
5. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service;BMJ Open;2024-01
2. Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials;Frontiers in Cardiovascular Medicine;2023-06-12
3. Advances in the discovery of drugs that treat pulmonary arterial hypertension;Expert Opinion on Drug Discovery;2023-04-03
4. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator;European Heart Journal Open;2023-02-21
5. Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension;Journal of Clinical Medicine;2021-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3